# SLNO (Soleno Therapeutics Inc.) - SEC EDGAR Financial Statements

> Soleno Therapeutics Inc. reported $190.4M in revenue and net income of $96.04M for the fiscal year ended December 31, 2025, with a 98.6% gross margin and a 45.4% operating margin.

- Canonical: https://convexityos.com/fundamentals/SLNO
- Markdown: https://convexityos.com/fundamentals/SLNO.md
- SEC CIK: 0001484565
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:21 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001484565&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $190.4M | Dec 31, 2025 |
| Operating Income | FY 2025 | $86.44M | 45.4% margin |
| Net Income | FY 2025 | $96.04M | 50.4% net margin |
| Diluted EPS | FY 2025 | $1.81 | Split-adjusted |
| Free Cash Flow | FY 2025 | $105.4M | 55.4% FCF margin |
| Cash & ST Investments | Mar 31, 2026 | $255.6M | Total debt: $54.28M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $190.4M | -- | -- | -- | -- | -- | -- | -- | -- | $1.45M |
| Cost of Revenue | $2.70M | -- | -- | -- | -- | -- | -- | -- | -- | $1.51M |
| **Gross Profit** | $187.7M | -- | -- | -- | -- | -- | -- | -- | -- | -$59K |
| Research & Development | $40.63M | $78.57M | $25.19M | $15.27M | $21.45M | $23.19M | $16.27M | $7.18M | $3.07M | $2.25M |
| Selling, General & Admin | $132.1M | $105.9M | $13.48M | -- | -- | -- | -- | -- | $6.61M | $6.08M |
| Total Operating Expenses | $181.0M | $187.7M | $41.38M | $24.40M | $31.53M | $36.29M | $23.49M | $14.30M | $12.17M | $8.32M |
| **Operating Income** | $9.41M | -$187.7M | -$41.38M | -$24.40M | -$31.53M | -$36.29M | -$23.49M | -$14.30M | -$12.17M | -$8.32M |
| **EBITDA** | $11.43M | -$185.7M | -$39.43M | -$22.43M | -$29.57M | -$34.34M | -$21.53M | -$12.34M | -$10.56M | -$8.31M |
| Interest Income | $16.95M | $12.05M | $2.58M | $300K | -- | -- | -- | -- | -- | -- |
| Interest Expense | $5.48M | $231K | $0 | $0 | -- | -- | -- | -- | -- | -- |
| Income Before Tax | $20.89M | -$175.8M | -$38.99M | -$24.07M | -$30.91M | -$24.64M | -$30.77M | -$11.84M | -$13.44M | -$6.74M |
| Income Tax Expense | $0 | $0 | $0 | -- | -- | -- | -- | $0 | -$1.65M | $0 |
| **Net Income** | $20.89M | -$175.8M | -$38.99M | -$24.07M | -$30.91M | -$24.64M | -$30.77M | -$13.34M | -$15.38M | -$12.07M |
| Basic EPS | $0.40 | -$4.38 | -$2.36 | -$2.87 | -$1,017.42 | -$1,024.43 | -$2,364.06 | -$1,681.11 | -$4,491.71 | -$13,317.53 |
| **Diluted EPS** | $0.39 | -$4.38 | -$2.36 | -$2.87 | -$1,017.42 | -$1,024.43 | -$2,364.06 | -$1,681.11 | -$4,491.71 | -$13,317.53 |
| Basic Shares Outstanding | 50.8M | 40.2M | 16.5M | 8.4M | 30.4K | 23.8K | 13.0K | 8.0K | 3.4K | 1.2K |
| Diluted Shares Outstanding | 52.4M | 40.2M | 16.5M | 8.4M | 30.4K | 23.8K | 13.0K | 8.0K | 3.4K | 1.2K |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $94.60M | -- | $66.02M | $32.66M | -- | -- | -- | -- |
| Cost of Revenue | $1.20M | -- | $1.14M | $696K | -- | -- | -- | -- |
| **Gross Profit** | $93.41M | -- | $64.88M | $31.96M | -- | -- | -- | -- |
| Research & Development | $11.27M | $9.56M | $8.40M | $9.15M | $13.52M | $21.49M | $30.14M | $12.34M |
| Selling, General & Admin | $50.37M | $40.88M | $33.75M | $28.24M | $29.26M | $37.30M | $49.20M | $10.89M |
| Total Operating Expenses | $63.33M | $52.15M | $43.91M | $39.18M | $45.74M | $59.12M | $80.21M | $24.87M |
| **Operating Income** | $31.28M | $39.58M | $22.11M | -$6.53M | -$45.74M | -$59.12M | -$80.21M | -$24.87M |
| **EBITDA** | $31.79M | $40.09M | $22.61M | -$6.02M | -$45.24M | -$58.61M | -$79.71M | -$24.37M |
| Interest Income | $4.93M | $5.13M | $5.30M | $3.19M | $3.33M | $3.37M | $3.60M | $3.01M |
| Interest Expense | $1.29M | $1.35M | $1.39M | $1.38M | $1.36M | -- | -- | -- |
| Income Before Tax | $34.91M | -- | -- | -- | -$43.77M | -- | -- | -- |
| Income Tax Expense | $3.54M | -- | -- | -- | $0 | -- | -- | -- |
| **Net Income** | $31.38M | $43.36M | $26.01M | -$4.71M | -$43.77M | -$55.98M | -$76.62M | -$21.85M |
| Basic EPS | $0.60 | -- | $0.49 | -$0.09 | -$0.95 | -- | -$1.83 | -$0.57 |
| **Diluted EPS** | $0.59 | -- | $0.47 | -$0.09 | -$0.95 | -- | -$1.83 | -$0.57 |
| Basic Shares Outstanding | 52.1M | -- | 53.3M | 50.5M | 46.2M | -- | 41.9M | 38.6M |
| Diluted Shares Outstanding | 53.1M | -- | 54.9M | 50.5M | 46.2M | -- | 41.9M | 38.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $70.11M | $87.93M | $169.7M | $14.60M | $21.30M | $49.22M | $20.73M | $23.10M | $17.10M | $2.73M |
| Short-Term Investments | $235.4M | $203.5M | -- | -- | -- | -- | -- | -- | -- | -- |
| **Cash & Short-Term Investments** | $305.5M | $291.4M | $169.7M | $14.60M | $21.30M | $49.22M | $20.73M | $23.10M | $17.10M | $2.73M |
| Accounts Receivable, Net | $28.21M | -- | -- | -- | -- | -- | -- | $0 | -- | $3.0K |
| Inventory | $15.02M | -- | -- | -- | -- | -- | -- | $0 | -- | $0 |
| **Total Current Assets** | $355.8M | $293.9M | $171.4M | $15.65M | $22.42M | $50.24M | $21.14M | $24.67M | $17.99M | $3.80M |
| Property, Plant & Equipment, Net | $185K | $186K | $12K | $26K | $33K | $19K | $22K | $12K | $23K | $42K |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- | $718K |
| Intangible Assets | $4.86M | $6.80M | $8.75M | $10.69M | $12.64M | $14.58M | $16.52M | $18.47M | $20.41M | $817K |
| Long-Term Investments | $200.6M | $27.21M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $163K | $83K | $165K | -- | $40K | $15K | $59K | -- | $126K | $126K |
| **Total Non-Current Assets** | $208.0M | $37.08M | $9.33M | $10.85M | $13.13M | $14.74M | $17.03M | $18.48M | $21.03M | $1.76M |
| **Total Assets** | $563.8M | $331.0M | $180.7M | $26.50M | $35.55M | $64.98M | $38.17M | $43.15M | $39.02M | $5.56M |
| Accounts Payable | $12.44M | $8.88M | $3.15M | $1.78M | $3.25M | $3.49M | $2.00M | $934K | $633K | $411K |
| Other Current Liabilities | $18.20M | $4.56M | $1.55M | $484K | $323K | $196K | $382K | $349K | -- | -- |
| **Total Current Liabilities** | $61.36M | $18.75M | $11.51M | $7.31M | $8.01M | $8.62M | $4.96M | $1.88M | $1.73M | $1.71M |
| Long-Term Debt | $49.86M | $49.83M | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Non-Current Liabilities | $525K | $21K | -- | -- | -- | -- | $147K | -- | $13K | $62K |
| **Total Non-Current Liabilities** | $52.35M | $67.11M | $11.68M | $8.84M | $9.75M | $10.82M | $18.26M | $10.86M | $10.47M | $422K |
| **Total Liabilities** | $113.7M | $85.86M | $23.18M | $16.15M | $17.76M | $19.43M | $23.23M | $12.74M | $12.21M | $2.13M |
| **Total Debt (incl. Leases)** | $52.55M | $52.83M | $403K | $155K | $457K | $147K | $470K | -- | -- | -- |
| Common Stock | $52K | $46K | $32K | $8.0K | $80K | $80K | $45K | $32K | $19K | $3.4K |
| Retained Earnings | -$431.4M | -$452.3M | -$276.4M | -$237.4M | -$213.4M | -$182.4M | -$157.8M | -$127.0M | -$113.7M | -$98.31M |
| Accumulated Other Comp. Income | $415K | $361K | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | $450.1M | $245.1M | $157.5M | $10.35M | $17.79M | $45.55M | $14.95M | $30.41M | $26.82M | $3.44M |
| Total Equity | $450.1M | $245.1M | $157.5M | $10.35M | $17.79M | $45.55M | $14.95M | $30.41M | $26.82M | $3.44M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $133.0M | $70.11M | $246.7M | $76.50M | $81.33M | $87.93M | $48.41M | $57.02M |
| Short-Term Investments | $122.6M | $235.4M | $252.3M | $210.3M | $208.6M | $203.5M | $208.4M | $209.1M |
| **Cash & Short-Term Investments** | $255.6M | $305.5M | $498.9M | $286.8M | $289.9M | $291.4M | $256.8M | $266.1M |
| Accounts Receivable, Net | $47.14M | $28.21M | $25.51M | $24.62M | -- | -- | -- | -- |
| Inventory | $17.31M | $15.02M | $6.67M | $2.35M | -- | -- | -- | -- |
| **Total Current Assets** | $326.4M | $355.8M | $534.9M | $316.8M | $308.9M | $293.9M | $258.2M | $267.5M |
| Property, Plant & Equipment, Net | $202K | $185K | $150K | $166K | $173K | $186K | $196K | $19K |
| Intangible Assets | $4.37M | $4.86M | $5.35M | $5.83M | $6.32M | $6.80M | $7.29M | $7.78M |
| Long-Term Investments | $273.4M | $200.6M | $57.15M | $7.00M | $0 | $27.21M | $27.95M | $28.48M |
| Other Non-Current Assets | $163K | $163K | $83K | $83K | $83K | $83K | $83K | $83K |
| **Total Non-Current Assets** | $282.0M | $208.0M | $65.04M | $15.52M | $9.18M | $37.08M | $38.51M | $36.63M |
| **Total Assets** | $608.4M | $563.8M | $599.9M | $332.3M | $318.1M | $331.0M | $296.7M | $304.1M |
| Accounts Payable | $12.39M | $12.44M | $8.14M | $6.22M | $5.48M | $8.88M | $6.24M | $3.72M |
| Other Current Liabilities | $24.93M | $18.20M | $17.16M | $5.51M | $3.13M | $4.56M | $3.10M | $1.13M |
| **Total Current Liabilities** | $58.05M | $61.36M | $33.25M | $20.94M | $15.73M | $18.75M | $14.96M | $9.15M |
| Long-Term Debt | $49.87M | $49.86M | $49.85M | $49.84M | $49.84M | $49.83M | -- | -- |
| Other Non-Current Liabilities | $1.43M | $525K | $398K | $271K | $145K | $21K | -- | -- |
| **Total Non-Current Liabilities** | $54.54M | $52.35M | $71.84M | $71.22M | $70.10M | $67.11M | $17.05M | $14.22M |
| **Total Liabilities** | $112.6M | $113.7M | $105.1M | $92.17M | $85.83M | $85.86M | $32.01M | $23.37M |
| **Total Debt (incl. Leases)** | $54.28M | $52.55M | $52.66M | $52.77M | $52.79M | $52.83M | $3.03M | $296K |
| Common Stock | $52K | $52K | $54K | $50K | $49K | $46K | $41K | $38K |
| Retained Earnings | -$400.0M | -$431.4M | -$474.7M | -$500.7M | -$496.0M | -$452.3M | -$396.3M | -$319.7M |
| Accumulated Other Comp. Income | -$1.84M | $415K | $360K | $85K | $226K | $361K | $895K | -$153K |
| **Total Stockholders' Equity** | $495.8M | $450.1M | $494.8M | $240.1M | $232.3M | $245.1M | $264.7M | $280.8M |
| Total Equity | $495.8M | $450.1M | $494.8M | $240.1M | $232.3M | $245.1M | $264.7M | $280.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $20.89M | -$175.8M | -$38.99M | -$24.07M | -$30.91M | -$24.64M | -$30.77M | -$13.34M | -$15.38M | -$12.07M |
| Depreciation & Amortization | $2.02M | $1.99M | $1.96M | $1.96M | $1.96M | $1.95M | $1.96M | $1.96M | $1.61M | $19K |
| Stock-Based Compensation | $45.85M | $99.96M | $5.95M | $2.53M | $3.28M | $1.50M | $825K | $1.26M | $880K | $739K |
| Change in Receivables | -$28.21M | $0 | $0 | -- | -- | -- | -- | -- | -- | $23K |
| Change in Inventory | -$14.03M | $0 | $0 | -- | -- | -- | -- | -- | -- | -$109K |
| Change in Payables | $3.61M | $5.67M | $1.37M | -$1.48M | -$235K | $1.49M | $1.06M | $249K | $191K | -$77K |
| **Operating Cash Flow** | $46.80M | -$69.10M | -$24.94M | -$20.78M | -$27.77M | -$25.22M | -$17.38M | -$11.68M | -$9.95M | -$13.50M |
| Capital Expenditure | -$73K | -$218K | $0 | -$13K | -$22K | -$7.0K | -$21K | -$8.0K | -$2.0K | -$15K |
| **Free Cash Flow** | $46.73M | -$69.31M | -$24.94M | -$20.79M | -$27.79M | -$25.23M | -$17.40M | -$11.69M | -$9.95M | -$13.51M |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -- | -- | -$573K | $0 |
| Purchases of Investments | -$455.8M | -$356.5M | $0 | $0 | -- | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$201.8M | -$225.7M | $0 | -$13K | -$22K | -$7.0K | $528K | -$180K | $154K | -$39K |
| Common Stock Issued | $215.7M | $149.0M | $0 | $0 | -- | -- | -- | -- | $10.00M | $0 |
| Share Repurchases | -$100.1M | $0 | $0 | -- | -- | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $137.2M | $213.0M | $180.0M | $14.09M | -$128K | $53.72M | $14.48M | $17.83M | $24.17M | $10.77M |
| **Net Change in Cash** | -$17.82M | -$81.75M | $155.1M | -$6.70M | -$27.92M | $28.49M | -$2.37M | $5.96M | $14.37M | -$2.77M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $31.38M | $43.36M | $26.01M | -$4.71M | -$43.77M | -$55.98M | -$76.62M | -$21.85M |
| Depreciation & Amortization | $514K | $509K | $502K | $502K | $504K | $503K | $500K | $494K |
| Stock-Based Compensation | $16.06M | $11.47M | $10.00M | $9.70M | $14.68M | $29.75M | $56.60M | $7.16M |
| Change in Receivables | -$18.93M | -$2.70M | -$882K | -$24.62M | $0 | -- | -- | -- |
| Change in Inventory | -$1.83M | -$8.02M | -$3.92M | -$2.10M | $0 | -- | -- | -- |
| Change in Payables | -$2.97M | $4.29M | $1.93M | $733K | -$3.34M | $2.58M | $2.53M | -$4.30M |
| **Operating Cash Flow** | $25.98M | $48.70M | $43.45M | -$12.61M | -$32.75M | -$23.99M | -$14.93M | -$17.65M |
| Capital Expenditure | -$40K | -$58K | -$1.0K | -$9.0K | -$5.0K | -$8.0K | -$191K | -$8.0K |
| **Free Cash Flow** | $25.94M | $48.65M | $43.45M | -$12.62M | -$32.76M | -$24.00M | -$15.12M | -$17.66M |
| Purchases of Investments | -$101.3M | -$187.8M | -$163.2M | -$59.41M | -$45.36M | -$47.55M | -$47.77M | -$145.9M |
| **Investing Cash Flow** | $37.98M | -$125.4M | -$91.44M | -$7.92M | $22.94M | $6.44M | $4.04M | -$120.9M |
| Share Repurchases | -$4.0K | -- | -- | -- | $0 | -- | -- | -- |
| **Financing Cash Flow** | -$1.04M | -$99.90M | $218.2M | $15.69M | $3.22M | $57.06M | $2.27M | $152.7M |
| **Net Change in Cash** | $62.92M | -$176.6M | $170.2M | -$4.83M | -$6.60M | $39.52M | -$8.61M | $14.18M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 98.6% | -- | -- | -- | -- | -- | -- | -- | -- | -4.0% |
| **Operating Margin** | 4.9% | -- | -- | -- | -- | -- | -- | -- | -- | -573.8% |
| **Net Profit Margin** | 11.0% | -- | -- | -- | -- | -- | -- | -- | -- | -831.6% |
| Return on Equity (ROE) | 4.6% | -71.7% | -24.8% | -232.6% | -173.7% | -54.1% | -205.9% | -43.8% | -57.4% | -351.2% |
| Return on Assets (ROA) | 3.7% | -53.1% | -21.6% | -90.8% | -86.9% | -37.9% | -80.6% | -30.9% | -39.4% | -216.8% |
| Current Ratio | 5.80x | 15.68x | 14.89x | 2.14x | 2.80x | 5.83x | 4.26x | 13.14x | 10.38x | 2.23x |
| Quick Ratio | 5.55x | 15.55x | 14.75x | 2.00x | 2.66x | 5.71x | 4.18x | 13.14x | 9.87x | 2.23x |
| Debt to Equity | 0.12x | 0.22x | 0.00x | 0.01x | 0.03x | 0.00x | 0.03x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -- | -- | +138.8% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -123.0% |
| 10Y Revenue / Share Growth | -97.8% | -- | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | 19.4% | 4.6% | -15.9% | -75.4% | -85.3% | -71.7% | -49.6% | -23.3% |
| Return on Assets (ROA) | 15.8% | 3.7% | -13.1% | -54.5% | -62.3% | -53.1% | -44.2% | -21.5% |
| Current Ratio | 5.62x | 5.80x | 16.08x | 15.13x | 19.64x | 15.68x | 17.26x | 29.24x |
| Quick Ratio | 5.32x | 5.55x | 15.88x | 15.01x | 18.43x | 15.55x | 17.16x | 29.08x |
| Debt to Equity | 0.11x | 0.12x | 0.11x | 0.22x | 0.23x | 0.22x | 0.01x | 0.00x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
